Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CRACD | Human | 17beta-estradiol | multiple interactions | ISO | Cracd (Rattus norvegicus) | 6480464 | [Testosterone co-treated with Estradiol] results in increased expression of CRACD mRNA | CTD | PMID:32741896 | CRACD | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CRACD mRNA | CTD | PMID:20106945 and PMID:21632981 | CRACD | Human | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of CRACD mRNA | CTD | PMID:37199045 | CRACD | Human | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CRACD mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CRACD mRNA | CTD | PMID:32699268 | CRACD | Human | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of CRACD mRNA | CTD | PMID:21641981 | CRACD | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of CRACD intron | CTD | PMID:30157460 | CRACD | Human | alpha-pinene | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CRACD mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CRACD mRNA | CTD | PMID:32699268 | CRACD | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of CRACD gene | CTD | PMID:25304211 | CRACD | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of CRACD gene | CTD | PMID:25304211 | CRACD | Human | atrazine | affects methylation | ISO | Cracd (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of CRACD gene | CTD | PMID:35440735 | CRACD | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CRACD mRNA | CTD | PMID:21632981 | CRACD | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CRACD mRNA | CTD | PMID:32234424 | CRACD | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of CRACD promoter | CTD | PMID:27901495 | CRACD | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of CRACD 5' UTR | CTD | PMID:27901495 | CRACD | Human | bisphenol A | decreases expression | ISO | Cracd (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CRACD mRNA | CTD | PMID:25181051 | CRACD | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of CRACD gene | CTD | PMID:31601247 | CRACD | Human | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of CRACD gene | CTD | PMID:31601247 | CRACD | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of CRACD mRNA | CTD | PMID:26079696 | CRACD | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of CRACD mRNA | CTD | PMID:27392435 | CRACD | Human | coumarin | affects phosphorylation | EXP | | 6480464 | coumarin affects the phosphorylation of CRACD protein | CTD | PMID:35688186 | CRACD | Human | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CRACD mRNA | CTD | PMID:19167446 | CRACD | Human | coumestrol | decreases expression | EXP | | 6480464 | Coumestrol results in decreased expression of CRACD mRNA | CTD | PMID:19167446 | CRACD | Human | dextran sulfate | increases expression | ISO | Cracd (Mus musculus) | 6480464 | Dextran Sulfate results in increased expression of CRACD mRNA | CTD | PMID:35093514 | CRACD | Human | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of CRACD mRNA | CTD | PMID:28302478 | CRACD | Human | endosulfan | increases expression | ISO | Cracd (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of CRACD mRNA | CTD | PMID:29391264 | CRACD | Human | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CRACD mRNA | CTD | PMID:19167446 | CRACD | Human | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of CRACD protein | CTD | PMID:37730182 | CRACD | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of CRACD gene | CTD | PMID:31601247 | CRACD | Human | lead(0) | affects splicing | EXP | | 6480464 | Lead affects the splicing of CRACD mRNA | CTD | PMID:28903495 | CRACD | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CRACD mRNA | CTD | PMID:35811015 | CRACD | Human | methapyrilene | increases methylation | ISO | Cracd (Rattus norvegicus) | 6480464 | Methapyrilene results in increased methylation of CRACD gene | CTD | PMID:26431795 | CRACD | Human | methoxychlor | affects methylation | ISO | Cracd (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of CRACD gene | CTD | PMID:35440735 | CRACD | Human | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CRACD mRNA more ... | CTD | PMID:32699268 | CRACD | Human | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of CRACD mRNA | CTD | PMID:21632981 | CRACD | Human | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CRACD mRNA | CTD | PMID:35811015 | CRACD | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of CRACD mRNA | CTD | PMID:31533062 | CRACD | Human | testosterone | multiple interactions | ISO | Cracd (Rattus norvegicus) | 6480464 | [Testosterone co-treated with Estradiol] results in increased expression of CRACD mRNA | CTD | PMID:32741896 | CRACD | Human | trichloroethene | increases expression | ISO | Cracd (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of CRACD mRNA | CTD | PMID:33387578 | CRACD | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of CRACD mRNA | CTD | PMID:24935251 | CRACD | Human | triptonide | increases expression | ISO | Cracd (Mus musculus) | 6480464 | triptonide results in increased expression of CRACD mRNA | CTD | PMID:33045310 | CRACD | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of CRACD gene | CTD | PMID:29154799 | CRACD | Human | valproic acid | affects splicing | ISO | Cracd (Rattus norvegicus) | 6480464 | Valproic Acid affects the splicing of CRACD mRNA | CTD | PMID:29427782 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
